Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone
antagonist (GnRH antagonist). It is primarily used in oncology to reduce the ...
Learn about the prescription medication Plenaxis (Abarelix), drug uses, dosage,
side effects, drug interactions, warnings, reviews and patient labeling.
Jun 13, 2005 ... Name, Abarelix. Accession Number, DB00106 (BTD00051, BIOD00051). Type,
Biotech. Groups, Approved, Investigational, Withdrawn.
Depot formulations of abarelix (abarelix-depot-M and abarelix-depot-F) are being
developed for hormonally responsive prostate cancer and endometriosis, ...
Plenaxis (abarelix for injectable suspension): For treatment of advanced prostate
cancer. New approved drug details including side effects, uses and general ...
BJU Int. 2009 Dec;104(11):1580-4. doi: 10.1111/j.1464-410X.2009.08924.x.
Abarelix and other gonadotrophin-releasing hormone antagonists in prostate ...
(abarelix for injectable suspension). WARNING. Immediate-onset systemic
allergic reactions, some resulting in hypotension and syncope, have occurred
Looking for online definition of abarelix in the Medical Dictionary? abarelix
explanation free. What is abarelix? Meaning of abarelix medical term. What does
Class: Hormonal therapy. Generic Name: Abarelix Trade Name: Plenaxis™. For
which conditions is this drug approved? Abarelix is FDA approved for the ...
Oct 23, 2015 ... Abarelix|Plenaxis<sup>®</sup>|50|2008. StartServiceArzneistoffeAbarelix|Plenaxis|50|2008 ·
Hier klicken! NEUE ARZNEISTOFFE ...